Development of oral capsules from Enterica herbal decoction-a traditional remedy for typhoid fever in Ghana.

The study aimed to develop oral capsules from Enterica herbal decoction used in Ghana for the treatment of typhoid fever and produced by the Centre for Scientific Research into Plant Medicine (CSRPM). The amount of dry extract per dose (30ml) of Enterica and the wavelength of maximum absorption (λmax) of aqueous solutions of Enterica extract were determined. Light magnesium carbonate (LMC) and maize starch (MS) were employed as absorbents at various concentrations in the preparation of granules of the extract. The % loss in weight, size distribution and flow properties of the granules were evaluated. Enterica oral capsules were formulated using LMC at 22 mg/dose of extract and the dissolution properties of the granules and capsules were determined by UV-VIS spectrophotometry. The dry Enterica extract/dose was 190.1 ± 0.12 mg and λmax was 356 nm. The loss of granules was 2.07-7.31 %w/w for LMC and 2.73-7.81 %w/w for MS. LMC granules (22 mg/dose) prepared for encapsulation exhibited good flow properties. The granules for encapsulation exhibited optimal release of extract (86.08 ± 1.64 % at 45 min) in aqueous medium. The formulated capsules passed the British Pharmacopoeia uniformity of weight, disintegration and dissolution tests. Enterica oral capsules can be used as a substitute for Enterica decoction for the treatment of typhoid fever.

Potential of aqueous extract of Hibiscus sabdariffa calyces as colorin agent in three pediatric oral pharmaceutical formulations.

Aqueous extracts of Roselle or Hibiscus sabdariffa L calyces have characteristic intense red colouration due to the presence of anthocyanins which could be utilised as colouring agent in pharmaceutical products. The aim of the current study was to evaluate the potential of aqueous extract of H. sabdariffa calyces as a colouring agent in three pediatric oral pharmaceutical formulations. The colour value of H. sabdariffa calyx extract was determined colorimetrically at λmax 540 nm to be within the BP range of ≥ 0.25. The colour value of H. sabdariffa (0.26) was lower than that of amaranth (0.46), a synthetic commercial pharmaceutical colourant. H. sabdariffa calyx extract retained its colour value within the BP standard for up to six months. The aqueous extract of H. sabdariffa calyces at 33 % w/v was used as colouring agent in paracetamol syrup, diphenhydramine syrup and pediatric cough linctus and the colour stability of the formulations against temperature, light and pH were determined. H. sabdariffa calyx extract was less stable than amaranth to temperature, light and pH when used as a colouring agent. H. sabdariffa calyx extract at 33 % w/v has potential as a colouring agent in pharmaceutical formulations when buffered at pH 5.0, packaged in amber bottles and stored at low temperatures (26-37 °C).